FRANZINI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 9.473
EU - Europa 6.598
AS - Asia 4.863
SA - Sud America 1.057
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 95
OC - Oceania 11
Totale 22.214
Nazione #
US - Stati Uniti d'America 8.946
SG - Singapore 1.689
IT - Italia 1.622
GB - Regno Unito 1.509
CN - Cina 1.262
RU - Federazione Russa 1.242
BR - Brasile 841
VN - Vietnam 766
UA - Ucraina 491
DE - Germania 361
PL - Polonia 357
CA - Canada 343
HK - Hong Kong 342
BD - Bangladesh 295
FI - Finlandia 252
FR - Francia 187
DK - Danimarca 153
SE - Svezia 147
IN - India 98
IE - Irlanda 90
MX - Messico 84
AR - Argentina 76
NL - Olanda 64
ID - Indonesia 54
TR - Turchia 50
KR - Corea 49
IQ - Iraq 46
JP - Giappone 41
EC - Ecuador 39
ZA - Sudafrica 39
IL - Israele 33
ES - Italia 25
PK - Pakistan 24
CL - Cile 23
CO - Colombia 21
VE - Venezuela 19
MA - Marocco 18
LT - Lituania 17
AT - Austria 16
CR - Costa Rica 16
EU - Europa 16
MY - Malesia 15
UZ - Uzbekistan 15
PY - Paraguay 14
CH - Svizzera 13
SA - Arabia Saudita 13
JM - Giamaica 12
RO - Romania 12
SK - Slovacchia (Repubblica Slovacca) 12
EG - Egitto 11
NI - Nicaragua 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
HN - Honduras 10
KE - Kenya 10
DZ - Algeria 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
NP - Nepal 8
SV - El Salvador 8
TN - Tunisia 8
GP - Guadalupe 7
AZ - Azerbaigian 6
BO - Bolivia 6
GT - Guatemala 6
JO - Giordania 6
PH - Filippine 6
PR - Porto Rico 6
AU - Australia 5
BE - Belgio 5
SN - Senegal 5
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
UY - Uruguay 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
AM - Armenia 2
GD - Grenada 2
GR - Grecia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
TH - Thailandia 2
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 22.115
Città #
Dallas 1.340
Southend 1.186
Singapore 884
Ashburn 752
San Jose 705
Council Bluffs 537
Beijing 536
Chandler 413
Warsaw 351
Hong Kong 308
San Mateo 287
Pisa 248
Fairfield 240
Woodbridge 235
Jacksonville 230
Milan 222
Ann Arbor 208
Moscow 208
Houston 197
Ho Chi Minh City 174
Helsinki 164
Cambridge 162
Los Angeles 162
Wilmington 162
The Dalles 156
Seattle 149
Dong Ket 140
New York 130
Dearborn 129
Boardman 128
Falls Church 127
Hanoi 127
Rome 116
Santa Clara 105
Columbus 95
Stevenage 92
Hefei 91
Beauharnois 86
São Paulo 86
Dublin 84
Portsmouth 82
Ottawa 80
Lauterbourg 77
Lawrence 74
Buffalo 67
Brooklyn 48
Phoenix 43
Montreal 41
Montréal 40
Bologna 39
Munich 39
Naples 37
Chicago 36
Tokyo 36
Mexico City 34
Seoul 34
Figino 33
Florence 33
Orem 33
Turin 33
Da Nang 32
London 32
Toronto 29
Rio de Janeiro 28
Tel Aviv 28
San Diego 27
Denver 26
Johannesburg 26
Amsterdam 24
San Francisco 23
Atlanta 22
Haiphong 22
North Bergen 22
Boston 21
Chennai 21
Kansas City 21
Brasília 20
Frankfurt am Main 20
Redwood City 20
Stockholm 20
Baghdad 18
Manchester 17
Catania 15
Nuremberg 15
Old Bridge 15
Poplar 15
Charlotte 14
Genoa 14
Quito 14
Tashkent 14
Ankara 13
Bari 13
Biên Hòa 13
Norwalk 13
Potenza 13
Santiago 13
Istanbul 12
Jakarta 12
Palermo 12
Pavia 12
Totale 13.452
Nome #
A High Performance Gel Filtration Chromatography Method for gamma-Glutamyltransferase Fraction Analysis 503
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 483
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 444
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 409
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 404
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 388
Gamma-glutammiltransferasi (GGT): biochimica clinica e patologia umana (Rassegna) 372
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 354
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 346
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 344
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 342
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 327
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 320
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 315
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. 313
RNA-targeting and gene editing therapies for transthyretin amyloidosis 312
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 312
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 308
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 301
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 299
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 297
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 288
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 287
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. 287
Marcatori di rimodellamento e fibrosi cardiaca 284
Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration. 283
Circulating gamma-glutamyltransferase fractions in cirrhosis. 282
Indici di laboratorio di stress ossidativo. 281
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 280
A novel marker of progression for atherosclerosis and cardiovascular diseases: serum gamma-glutamyltransferase enzyme activity. 272
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 271
Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells? 268
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 261
gamma-Glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. 255
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 253
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 252
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 252
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 241
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 238
The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. 233
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 229
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases. 229
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study. 228
Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. 226
State of the Art of Immunoassay Methods for B-Type Natriuretic Peptides: an Update 225
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials 222
Valutazione di un metodo di dosaggio del BNP nel sangue capillare 222
State of the art of aldosterone immunoassays. 222
Valutazione delle prestazioni analitiche del nuovo metodo per il dosaggio dell’aldosterone che utilizza la piattaforma LIAISON: confronto con altri metodi immunometrcici e con la psettrometria di massa 215
Use of biomarkers to diagnose and manage cardiac amyloidosis 214
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values. 211
Gamma-glutamyltransferase fractions in human plasma and bile: Characteristic and biogenesis 210
Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. 209
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 207
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? 207
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 207
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi 206
Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. 206
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 201
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. 199
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians. 199
Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting 198
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 197
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 196
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained 194
Vitamin C supply to bronchial epithelial cells linked to glutathione availability in elf - A role for secreted gamma-glutamyltransferase. 193
gamma-glutamiltransferasi e stress ossidativo. 193
Pathophysiology of Cardiac Amyloidosis 192
Stato dell’arte del dosaggio dei peptidi BNP e NT-proBNP: il controllo di qualità esterno CardioOrmoCheck 192
Gamma-glutamyltransferase, H(2)O(2)-induced apoptosis and expression of catalase. 191
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 191
Cystic fibrosis, elevated gamma-glutamyltransferase, and lung transplant outcome. 189
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 188
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. 187
Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. 186
PROCESS FOR DETERMINING S-NITROSOTHIOLS IN BIOLOGICALFLUIDS 184
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 184
Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections 184
Serum gamma-glutamyltransferase fractions in Myotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease. 180
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 179
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 178
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 178
Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. 178
Gamma-glutamyltransferases: exploring the complexity of a multifunctional family of enzymes 167
Plasma gamma-glutamyltransferase (GGT) activity in inflammatory bowel disease: is the clinical laboratory plasma GGT assay sensitive enough for gastroenterology? 162
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 154
Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos 141
Biological variability of transthyretin in patients with transthyretin cardiac amyloidosis: implications for therapy monitoring 104
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 97
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 79
Profiling plasma transthyretin in healthy subjects and patients with cardiac ATTR amyloidosis by native electrophoresis 65
Reflection-mode fiber optic biosensor integrating FBG and short period-LPG for real-time detection of fPSA 58
Totale 22.214
Categoria #
all - tutte 106.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022772 0 0 0 77 27 28 128 219 66 132 18 77
2022/2023965 80 31 26 163 142 177 19 74 178 15 41 19
2023/2024543 50 24 76 27 17 74 47 44 19 21 48 96
2024/20253.226 46 36 148 77 121 199 506 964 234 143 513 239
2025/20269.370 401 1.494 987 1.141 821 568 1.102 386 582 647 501 740
2026/20271.722 251 351 578 542 0 0 0 0 0 0 0 0
Totale 22.214